FDA Approves Amitiza For IBS-C - Only Drug Available In USA For Irritable Bowel Syndrome With Constipation
May 15th 2008Drug InformationIrritable-Bowel Syndrome
The U.S. Food and Drug Administration approved Amitiza (lubiprostone) for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in adult women aged 18 and over. There is currently no prescription drug therapy for IBS-C. With this approval, Amitiza becomes the only FDA-approved medical treatment for IBS-C available in the United States. Irritable bowel syndrome is a disorder characterized by cramping, abdominal pain, bloating, constipation, and diarrhea.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
